Claro Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$391K Buy
1,325
+44
+3% +$13.1K 0.05% 298
2025
Q4
$350K Sell
1,281
-1
-0.1% -$272 0.05% 295
2025
Q3
$346K Sell
1,282
-48
-4% -$13.1K 0.05% 292
2025
Q2
$367K Sell
1,330
-1,658
-55% -$451K 0.06% 254
2025
Q1
$793K Buy
2,988
+264
+10% +$65.1K 0.11% 176
2024
Q4
$633K Sell
2,724
-311
-10% -$71.5K 0.09% 210
2024
Q3
$670K Buy
+3,035
New +$628K 0.09% 224
2019
Q1
Sell
-551
Closed -$94K 290
2018
Q4
$94K Buy
+551
New +$102K 0.08% 239

Other funds holding CME

Claro Advisors's CME Position: Q1 2026 in Review

Claro Advisors increased its CME Group (CME) stake by 3.4% in Q1 2026, buying an estimated $13.1K and bringing the position to 1,325 shares worth $391K. The position accounts for 0.05% of the portfolio, ranked #298.

Claro Advisors first reported a position in CME in Q4 2018 and has held it in 8 quarters since. The position peaked at $793K in Q1 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Claro Advisors held 1,325 shares of CME Group worth $391K as of Q1 2026.
  • Claro Advisors bought 44 CME Group shares in Q1 2026, an estimated $13.1K.
  • CME Group made up 0.05% of Claro Advisors's portfolio in Q1 2026, its #298 holding.
  • Claro Advisors first reported a position in CME Group in Q4 2018 and has held it in 8 quarters since.
  • Claro Advisors's CME Group position peaked at $793K in Q1 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.